latest news on glp 1 drugs GLP-1 weight loss leave users low key nutrients, study finds Medicare is about to cover

Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: Theoretical consideration and therapeutic potential

A nationwide register-based cohort and self-controlled case series study

Cases AI, et al

As previously mentioned, patients with T2D on incretin-based therapies showed significant weight loss and improved glycemic control with little experience of hypoglycemia (47)

In this article, well explore how manufacturers can invest their capital budgets with these advances in mind, positioning themselves to ride this wave of demand into a promising future

Practical approaches include: sipping fluids throughout the day rather than drinking large volumes at once, choosing beverages with electrolytes when experiencing gastrointestinal symptoms, and setting reminders to drink regularly